SCHEMBL5515906

SCHEMBL5515906

CC(C)C(C)(C)C(=O)N1CCCC(C(N)=O)C1

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
MAPK1 P28482 1/20 0.50
LMNA P02545 2/20 0.49
HSD17B10 Q99714 2/20 0.45
GLA P06280 1/20 0.45
KMT2A Q03164 2/20 0.41
BCHE P06276 1/20 0.40
KDM4E B2RXH2 2/20 0.40
RAB9A P51151 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5517785 0.86 ALDH1A1 (0.42) ALDH1A1MAPK1LMNAHSD17B10KMT2A
SCHEMBL11922853 0.84 ALDH1A1 (0.55) ALDH1A1MAPK1LMNAHSD17B10GLA
SCHEMBL2746556 0.83 ALDH1A1 (0.54) ALDH1A1MAPK1LMNAHSD17B10GLA
SCHEMBL5540743 0.82 BCHE (0.43) ALDH1A1MAPK1LMNAKMT2ABCHE
SCHEMBL5536454 0.82 BCHE (0.48) ALDH1A1MAPK1LMNAKMT2ABCHE
SCHEMBL10264939 0.82 ITGB3 (0.46) ALDH1A1MAPK1LMNAKMT2AKDM4E
SCHEMBL5516664 0.81 GAA (0.47) ALDH1A1KDM4EGAA
SCHEMBL14679349 0.80 ITGB3 (0.48) ALDH1A1RAB9AHPGD
SCHEMBL5511891 0.79 ALDH1A1 (0.59) ALDH1A1LMNAKDM4ERAB9AHPGD
SCHEMBL13688865 0.79 ALDH1A1 (0.50) ALDH1A1MAPK1LMNAHSD17B10GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed